Excelsior Biopharma

Excelsior Biopharma EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Excelsior Biopharma (6496.TWO) as of Oct 31, 2026 is -7.73. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -3.80 — a change of 103.19% (lower).

EV/FCF

-7.73

YoY

103.19%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Excelsior Biopharma is 2025 -7.73 . EV/FCF (Enterprise Value to Free Cash Flow) of Excelsior Biopharma was 2024 -3.80 . It decreases by 103.19% lower compared to the previous year.

The Excelsior Biopharma EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
10.63 TWD
Jan 1, 2019
-6.56 TWD
Jan 1, 2020
0.96 TWD
Jan 1, 2021
10.24 TWD
Jan 1, 2022
-225.11 TWD
Jan 1, 2023
-6.07 TWD
Jan 1, 2024
-3.80 TWD
Jan 1, 2025
-7.73 TWD
The Excelsior Biopharma EV/FCF history
YEAREV/FCFYoY
-7.73+103.19%
-3.80-37.39%
-6.07-97.30%
-225.11-2,298.47%
10.24+961.43%
0.96-114.70%
-6.56-161.74%
10.63+182.31%
3.77+26.68%
2.97-99.24%
392.73+4,773.83%
8.06—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

EV/FCF (Enterprise Value to Free Cash Flow) of Excelsior Biopharma is -7.73 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Excelsior Biopharma changed from -3.80 to -7.73, representing a 103.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Excelsior Biopharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Excelsior Biopharma

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Excelsior Biopharma